This information was published on 2023-03-30T04:10:32 for IP Right Filed Published.
Field | Value |
(210) | 2345712 (IR 1722241) |
(220) |
03 Mar 2023
|
(300) |
US, 20 Jan 2023, 97762199
|
(511) (510) |
Class 42
Pharmaceutical drug development services; pharmaceutical research and development; product design and development in the field of pharmaceuticals; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing of pharmaceuticals. |
(540) | AMBIFECT |
(550) | Word |
(730) |
Akston Biosciences Corporation
|
Find out more about publications on the About page.